methamphetamine and y 27632

methamphetamine has been researched along with y 27632 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Aoki, K; Kuzumaki, N; Narita, M; Suzuki, T; Takagi, M1
Dong, G; Kaibuchi, K; Liao, J; Liu, Y; Mizoguchi, H; Nabeshima, T; Nagai, T; Ozaki, N; Sawahata, M; Wulaer, B; Yamada, K; Zhu, W1

Other Studies

2 other study(ies) available for methamphetamine and y 27632

ArticleYear
Implication of Rho-associated kinase in the elevation of extracellular dopamine levels and its related behaviors induced by methamphetamine in rats.
    Journal of neurochemistry, 2003, Volume: 86, Issue:2

    Topics: 3,4-Dihydroxyphenylacetic Acid; Amides; Animals; Behavior, Animal; Central Nervous System Stimulants; Dopamine; Dopamine Uptake Inhibitors; Drug Administration Routes; Enzyme Inhibitors; Extracellular Space; Homovanillic Acid; Intracellular Signaling Peptides and Proteins; Male; Methamphetamine; Microdialysis; Morphine; Narcotics; Nucleus Accumbens; Protein Serine-Threonine Kinases; Pyridines; Rats; Rats, Sprague-Dawley; rho-Associated Kinases; Signal Transduction; Tetrodotoxin

2003
Rho kinase inhibitors ameliorate cognitive impairment in a male mouse model of methamphetamine-induced schizophrenia.
    Pharmacological research, 2023, Volume: 194

    Topics: Animals; Clozapine; Cognitive Dysfunction; Haloperidol; Male; Methamphetamine; Mice; Monomeric GTP-Binding Proteins; Protein Kinase Inhibitors; rho-Associated Kinases; Schizophrenia

2023